Patient's perception of exacerbations of COPD-the PERCEIVE study

Marc Miravitlles, Antonio Anzueto, Delfino Legnani, Leonhard Forstmeier, Matthias Fargel

Research output: Contribution to journalArticlepeer-review

119 Scopus citations

Abstract

The evaluation of therapies requires the development of patient-reported outcomes (PROs) that help clinicians to understanding the symptoms, perceptions and feelings of patients with exacerbations of chronic obstructive pulmonary disease (COPD). With the aim of obtaining information on the perceptions of patients with COPD, their exacerbations and expectations of treatment, a random telephone contact survey in six countries was performed. From 83,592 households screened, 1100 subjects with symptoms compatible with COPD were identified. The most frequent symptom was shortness of breath (78%). The most frequent complaint was that due to their COPD: "they could not complete the activities they like to do" (54%); 17% (187) of individuals were afraid that their COPD would cripple, or eventually kill them. Exacerbations generated a mean of 5.1 medical visits/year (sd=4.6) with the mean duration of exacerbation symptoms being 10.5 days. Increased coughing was the exacerbation symptom having the strongest impact on well-being (42%). Fifty-five percent of patients declared that quicker symptom relief was the most desired requirement for treatment. New data are provided on the impact of COPD and its exacerbations on the daily life of patients. These data will help to develop PROs designed to evaluate the effectiveness of different therapies for exacerbated COPD.

Original languageEnglish (US)
Pages (from-to)453-460
Number of pages8
JournalRespiratory Medicine
Volume101
Issue number3
DOIs
StatePublished - Mar 2007
Externally publishedYes

Keywords

  • COPD
  • Chronic bronchitis
  • Patient-reported outcomes
  • Respiratory symptoms

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Fingerprint

Dive into the research topics of 'Patient's perception of exacerbations of COPD-the PERCEIVE study'. Together they form a unique fingerprint.

Cite this